We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Medipharm Labs Corp (LABS) NPV

Sell:0.22 CAD Buy:0.23 CAD Change: 0.005 CAD (2.22%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Sell:0.22 CAD
Buy:0.23 CAD
Change: 0.005 CAD (2.22%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
Sell:0.22 CAD
Buy:0.23 CAD
Change: 0.005 CAD (2.22%)
Market closed |  Prices as at close on 26 November 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

MediPharm Labs Corp. is a Canada-based pharmaceutical company that is specialized in cannabis. The Company produces purified, pharmaceutical-like cannabis extracts and related derivative products. The Company formulates, processes, packages and distributes cannabis extracts and cannabinoid-based products at its Canadian and Australian facilities for domestic and international markets. The Company, through its subsidiaries is engaged in the sale and distribution of cannabis oil, cannabis extracts, cannabis edibles, cannabis topicals, and derivatives to authorized classes of purchasers, as well as controlled human administration trials for sensory testing of cannabis extracts and derivative products. It is also engaged in the manufacturing of extracts and tinctures of cannabis and cannabis resin for the purpose of a clinical trial or prescribed as medical cannabis products. The Company's wholly owned subsidiaries include MediPharm Labs Inc. and MediPharm Labs Australia Pty. Ltd.

Contact details

Address:
151 John Street
BARRIE
L4N 2L1
Canada
Telephone:
+1 (705) 7197425
Website:
https://www.medipharmlabs.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LABS
ISIN:
CA58504D1006
Market cap:
61.29 million CAD
Shares in issue:
266.50 million
Sector:
Pharmaceuticals
Exchange:
Toronto Stock Exchange
Country:
United States
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • Chris Taves
    Chairman of the Board
  • Keith Strachan
    President, Director
  • Bryan Howcroft
    Chief Executive Officer
  • Greg Hunter
    Chief Financial Officer
  • Warren Everitt
    Chief Executive Officer of Asia Pacific, Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.